SCHEMBL6555503

SCHEMBL6555503

CCOc1cc(Cc2cnc(N)nc2N)cc(OCC)c1-c1ccc(OS(C)(=O)=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557365 0.92 DHFR (0.56) DHFR
SCHEMBL6557367 0.92 DHFR (0.47) DHFR
SCHEMBL6555433 0.89 DHFR (0.52) DHFR
SCHEMBL6557348 0.88 DHFR (0.56) DHFR
SCHEMBL6556791 0.86 DHFR (0.66) DHFR
SCHEMBL6555280 0.86 DHFR (0.54) DHFR
SCHEMBL6557381 0.85 DHFR (0.56) DHFR
SCHEMBL6555131 0.85 DHFR (0.63) DHFR
SCHEMBL6555143 0.84 DHFR (0.52) DHFR
SCHEMBL6555383 0.84 DHFR (0.53) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed